Theravance, Inc. (NASDAQ: THRX) announced the results of two studies in an ongoing Phase 2b clinical program to assess the efficacy and safety of the investigational bronchodilators GSK642444 (‘444) and GSK159797 (‘797), the lead long-acting Beta2 agonist (LABA) compounds in the Beyond Advair collaboration with GlaxoSmithKline (GSK).
The Office of Fair Trading of UK (OFT) has today launched a market study into the distribution of medicines in the UK.
Younger siblings of children with autism spectrum disorders do not perform as well on tests of social and communication development compared with siblings of children without developmental problems at ages as young as 12 months, according to a report in the April issue of Archives of Pediatrics & Adolescent Medicine, a theme issue on autism spectrum disorders.
The BMA is to advise junior doctors on their options if they are not appointed to a new job through the discredited Medical Training Application Service (MTAS).
UC Davis today was named a partner in a new $18.5 million national research center that will study influenza viruses with pandemic potential, such as avian influenza H5N1 (“bird flu”).
In a ceremony, Gov. Bill Richardson signed into law a bill that makes New Mexico the 12th state to protect seriously ill patients from arrest for using medical marijuana with a doctor’s recommendation – prompting Minnesota lawmakers to call for similar protections here.
A research team at the University of Rochester Medical Center has been awarded $26 million to establish a research center with the goal of making seasonal influenza and future influenza pandemics less deadly.
Emerging genetic research may help scientists recognize children with autism at a younger and potentially treatable age, according to an editorial in the April issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The American College of Physicians (ACP) released a new clinical practice guideline for screening mammography for women 40 to 49 years of age.
The number of people in the U.S. with macular degeneration is greater than that with all types of cancer combined. Macular degeneration can lead to blindness, something that people fear even more than premature death. This award will help further research into this condition.